Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone for non-IPF ILD with UIP pattern (Phase 4, single-arm)
KCT0011963Phase 4Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pirfenidone in interstitial lung disease (ILD), sponsored by Asan Medical Center. Planned start May 2026; status: not yet recruiting.
02
Drugs
pirfenidone
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on KCT0011963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011963.